DIADEMA PARTNERS LP — 13F Holdings & Portfolio

CIK 2026172 · latest 13F-HR filed 2026-08-14

DIADEMA PARTNERS LP manages $791.3M in 13F-reported U.S. long-equity assets across 149 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are VKTX (6.02%), ABVX (5.88%), BMY (4.37%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 29 new positions and exited 37; 30 existing positions rose in reported value and 15 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$791.3M

Long-equity book

Holdings
149

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+29 / −37 / ↑30 / ↓15

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 62.5%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 20, 2026.

Assets Under Management
$397.9M
Discretionary
$397.9M
Employees
6
Accounts
7
Address
2140 HEADQUARTERS PLAZA
EAST TOWER 2ND FLOOR
MORRISTOWN, NJ 07960
Phone
(646) 979-8432
Name Title / Status Ownership Type
BASSETT, TIMOTHY, BEAU ControlCHIEF INVESTMENT OFFICER, LIMITED PARTNER
since Apr 2024
75% or moreIndividual
Canonico, Zachary, Kayn ControlCHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER
since Apr 2024
Less than 5%Individual
DIADEMA PARTNERS GENERAL PARTNER LLC ControlGENERAL PARTNER
since Apr 2024
Less than 5%Domestic Entity
BASSETT, TIMOTHY, BEAU Control
Indirect owner via DIADEMA PARTNERS GENERAL PARTNER LLC
MANAGING MEMBER
since Apr 2024
75% or moreIndividual

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

DIADEMA PARTNERS LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 VIKING THERAPEUTICS INC Call VKTX 92686J106 $47.6M 6.02% 1,220,800 SH
2 ABIVAX SA Call ABVX 00370M103 $46.5M 5.88% 349,200 SH
3 BRISTOL-MYERS SQUIBB CO Call BMY 110122108 $34.6M 4.37% 600,000 SH
4 ABIVAX SA Put ABVX 00370M103 $33.6M 4.25% 252,400 SH
5 UNITED THERAPEUTICS CORP DEL UTHR 91307C102 $28.7M 3.63% 52,989 SH
6 REVOLUTION MEDICINES INC RVMD 76155X100 $26.1M 3.29% 139,218 SH
7 ABIVAX SA ABVX 00370M103 $21.6M 2.73% 163,644 SH
8 COGENT BIOSCIENCES INC COGT 19240Q201 $19.1M 2.41% 493,664 SH
9 BRISTOL-MYERS SQUIBB CO Put BMY 110122108 $19.0M 2.41% 330,600 SH
10 BRIDGEBIO PHARMA INC BBIO 10806XAJ1 $18.6M 2.35% 250,000 PRN
11 CORCEPT THERAPEUTICS INC Call CORT 218352102 $17.9M 2.27% 206,300 SH
12 BIOMARIN PHARMACEUTICAL INC BMRN 09061G101 $17.9M 2.26% 312,846 SH
13 VIKING THERAPEUTICS INC VKTX 92686J106 $17.2M 2.18% 441,808 SH
14 KYMERA THERAPEUTICS INC Call KYMR 501575104 $17.2M 2.17% 149,700 SH
15 NOVARTIS AG Put NVS 66987V109 $15.7M 1.98% 100,000 SH
16 UNIQURE NV Put QURE N90064101 $13.8M 1.74% 299,000 SH
17 VIKING THERAPEUTICS INC Put VKTX 92686J106 $13.7M 1.73% 350,500 SH
18 BIOGEN INC Call BIIB 09062X103 $13.0M 1.64% 60,000 SH
19 CAPRICOR THERAPEUTICS INC Put CAPR 14070B309 $12.9M 1.63% 534,400 SH
20 SUMMIT THERAPEUTICS INC Call SMMT 86627T108 $12.5M 1.58% 860,200 SH
21 ELI LILLY & CO Put LLY 532457108 $12.0M 1.52% 10,000 SH
22 INCYTE CORP Put INCY 45337C102 $11.9M 1.51% 105,400 SH
23 EDGEWISE THERAPEUTICS INC EWTX 28036F105 $11.1M 1.40% 272,214 SH
24 UNIQURE NV Call QURE N90064101 $10.8M 1.37% 235,400 SH
25 BIONTECH SE Call BNTX 09075V102 $9.3M 1.18% 100,000 SH
26 KODIAK SCIENCES INC KOD 50015M109 $8.5M 1.07% 218,117 SH
27 IMMUNOCORE HLDGS PLC IMCR 45258D105 $8.1M 1.02% 254,863 SH
28 CAPRICOR THERAPEUTICS INC Call CAPR 14070B309 $7.9M 1.00% 329,300 SH
29 NOVARTIS AG Call NVS 66987V109 $7.8M 0.99% 50,000 SH
30 REPLIMUNE GROUP INC Call REPL 76029N106 $7.7M 0.97% 696,300 SH
31 KODIAK SCIENCES INC Call KOD 50015M109 $7.7M 0.97% 196,700 SH
32 4D MOLECULAR THERAPEUTICS IN FDMT 35104E100 $7.6M 0.96% 571,107 SH
33 MODERNA INC Put MRNA 60770K107 $7.0M 0.88% 100,000 SH
34 HIMS & HERS HEALTH INC Call HIMS 433000106 $6.9M 0.88% 200,000 SH
35 ARCUS BIOSCIENCES INC RCUS 03969F109 $6.9M 0.87% 223,810 SH
36 HIMS & HERS HEALTH INC Put HIMS 433000106 $6.7M 0.85% 193,700 SH
37 CORBUS PHARMACEUTICALS HLDGS Call CRBP 21833P301 $5.9M 0.75% 633,800 SH
38 SELLAS LIFE SCIENCES GROUP I Call SLS 81642T209 $5.9M 0.75% 400,000 SH
39 KODIAK SCIENCES INC Put KOD 50015M109 $5.7M 0.72% 146,900 SH
40 ALUMIS INC Call ALMS 022307102 $5.6M 0.71% 200,000 SH
41 ROYALTY PHARMA PLC Call RPRX G7709Q104 $5.6M 0.71% 100,000 SH
42 JOHNSON & JOHNSON JNJ 478160104 $5.6M 0.71% 22,000 SH
43 REPLIMUNE GROUP INC Put REPL 76029N106 $5.6M 0.70% 502,500 SH
44 BIOAGE LABS INC Call BIOA 09077V100 $4.9M 0.62% 200,100 SH
45 NOVO-NORDISK A S NVO 670100205 $4.8M 0.61% 100,000 SH
46 BIOHAVEN LTD Call BHVN G1110E107 $4.7M 0.60% 317,000 SH
47 TENAX THERAPEUTICS INC Call TENX 88032L605 $4.5M 0.56% 307,000 SH
48 CORVUS PHARMACEUTICALS INC CRVS 221015100 $4.4M 0.56% 294,811 SH
49 RELAY THERAPEUTICS INC RLAY 75943R102 $4.3M 0.55% 230,677 SH
50 TG THERAPEUTICS INC Call TGTX 88322Q108 $4.2M 0.53% 75,700 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $791.3M 149 0001892688-26-000119
2026-03-31 2026-05-15 $587.7M 144 0001892688-26-000076
2025-12-31 2026-02-17 $580.5M 145 0001892688-26-000036
2025-09-30 2025-11-14 $391.0M 130 0001892688-25-000193
Filer Information
Address
2140 HEADQUARTERS PLAZA
EAST TOWER, 2ND FLOOR
MORRISTOWN, NJ 07960
Phone
(917) 513-8539
Filing Manager
DIADEMA PARTNERS LP
MORRISTOWN, NJ
Signatory
Zachary Canonico
Chief Compliance Officer and Chief Operating Officer